Some medications affect more than just the target disease..
Various medications are commonly prescribing which involves macrolide antibiotics , fluoroquinolones, antipsychotics, and anti-arrhythmics they prolong the QT interval which leads to sudden cardiac death. Patients with electrolyte abnormalities, structural heart disease, or multiple QT-prolonging drugs are particularly vulnerable. Reviewing medication profiles, correcting electrolyte disturbances, and obtaining ECG monitoring in high-risk patients are essential strategies for improving patient safety.
Do you routinely review QT-prolonging medications before initiating therapy in high-risk patients?
MBH/PS